13F Filings History of Tower House Partners LLP

Latest 13F report
Q4 2022 - 14 Feb 2023
Value $
$16,816,000
Signature - Title
Peter Fox - COO
Location
London, United Kingdom
Summary
This page shows a list of all the recent 13F filings made by Tower House Partners LLP. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Tower House Partners LLP reported 3 stock holdings with total value $16,816,000 as of Q4 2022. Top holdings included CRL, AZTA, and FWONK.

Notify me when Tower House Partners LLP files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2022 3 $16,816,000 +$4,204,612 -$16,115,571 -$11,910,959 CRL, AZTA, FWONK 13F-HR 14 Feb 2023, 12:47
Q3 2022 3 $24,244,000 +$3,485,485 -$3,905,797 -$420,312 AZTA, CTLT, CRL 13F-HR 14 Nov 2022, 08:48
Q2 2022 3 $34,118,000 $0 -$15,887,254 -$15,887,254 CTLT, AZTA, CRL 13F-HR 15 Aug 2022, 15:04
Q1 2022 3 $57,381,000 $0 -$36,948,516 -$36,948,516 AZTA, CTLT, CRL 13F-HR 16 May 2022, 08:58
Q4 2021 3 $116,725,000 +$258,470 -$55,190,654 -$54,932,184 AZTA, CTLT, CRL 13F-HR 14 Feb 2022, 12:43
Q3 2021 5 $176,269,000 $0 -$24,194,306 -$24,194,306 AZTA, CTLT, CRL, BIO, CELL 13F-HR 15 Nov 2021, 12:27
Q2 2021 5 $192,063,000 +$897,711 -$36,493,928 -$35,596,217 AZTA, CRL, CTLT, BIO, CELL 13F-HR 17 Aug 2021, 12:05
Q1 2021 6 $205,434,000 +$28,971,000 -$44,319,856 -$15,348,856 AZTA, CRL, CTLT, BIO, CELL 13F-HR 17 May 2021, 08:21
Q4 2020 5 $205,034,000 +$18,872,000 -$43,025,502 -$24,153,502 AZTA, CRL, CTLT, BIO, BLFS 13F-HR 05 Mar 2021, 13:12
Q3 2020 5 $186,689,000 +$2,885,651 -$56,485,749 -$53,600,098 AZTA, CRL, BIO, CTLT, CYRX 13F-HR 16 Nov 2020, 07:15
Q2 2020 6 $206,743,000 +$84,159,000 -$64,819,118 +$19,339,882 AZTA, CRL, BIO, CTLT, BRKR 13F-HR 10 Aug 2020, 08:22
Q1 2020 3 $135,709,000 +$56,358,000 -$45,869,626 +$10,488,374 BIO, AZTA, CTLT 13F-HR 04 Jun 2020, 11:18
Q4 2019 3 $140,434,000 +$16,090,636 -$9,850,547 +$6,240,089 BIO, AZTA, OLLI 13F-HR 12 Feb 2020, 10:21
Q3 2019 3 $120,004,000 +$56,783,000 -$33,705,421 +$23,077,579 BIO, AZTA, OLLI 13F-HR 14 Nov 2019, 11:39
Q2 2019 2 $92,896,000 +$3,686,999 -$2,025,200 +$1,661,799 BIO, EA 13F-HR 14 Aug 2019, 11:54
Q1 2019 2 $90,051,000 +$32,521,000 -$11,247,397 +$21,273,603 BIO, EA 13F-HR 13 May 2019, 11:46
Q4 2018 1 $52,249,000 $0 $0 $0 BIO 13F-HR 13 Feb 2019, 17:11